Evidence map›Paper›PMID 33870248›Full record

ArticleThe Lancet regional health. Europe2021

Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020.

Anna Jeffery-Smith, Kate Dun-Campbell, Roshni Janarthanan, Jonathan Fok, Emma Crawley-Boevey, Amoolya Vusirikala, Elena Fernandez Ruiz De Olano, Marina Sanchez Perez, Suzanne Tang, Thomas Aj Rowland and 19 more

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Anna Jeffery-SmithVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Kate Dun-CampbellLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Roshni JanarthananLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Jonathan FokLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Emma Crawley-BoeveyLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Amoolya VusirikalaLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Elena Fernandez Ruiz De OlanoLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Marina Sanchez PerezLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Suzanne TangLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Thomas Aj RowlandVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Edward Wynne-EvansLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Anita BellLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Bharat PatelLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Zahin Amin-ChowdhuryImmunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Felicity AianoImmunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Karthik ParanthamanField Service, National Infection Service, Public Health England, UK.
Thomas MaField Service, National Infection Service, Public Health England, UK.
Maria Saavedra-CamposField Service, National Infection Service, Public Health England, UK.
Joanna EllisVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Angie LackenbyVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Heather WhitakerVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Richard MyersVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Katja HöschlerVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Kevin BrownImmunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Mary E RamsayImmunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Nandini ShettyVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
J Yimmy ChowLondon Health Protection team, National Infection Service, Public Health England, London, UK.
Shamez LadhaniImmunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Maria ZambonVirus Reference department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCare homes have been disproportionately affected by the COVID-19 pandemic. We investigated the potential role of asymptomatic infection and silent transmission in London care homes that reported no cases of COVID-19 during the first wave of the pandemic.

methodsFive care homes with no cases and two care homes reporting a single case of COVID-19 (non-outbreak homes) were investigated with nasal swabbing for SARS-CoV-2 RT-PCR and serology for SARS-CoV-2 antibodies five weeks later. Whole genome sequencing (WGS) was performed on RT-PCR positive samples. Serology results were compared with those of six care homes with recognised outbreaks.

findingsAcross seven non-outbreak homes, 718 (387 staff, 331 residents) individuals had a nasal swab and 651 (386 staff, 265 residents) had follow-up serology. Sixteen individuals (13 residents, 3 staff) in five care homes with no reported cases were RT-PCR positive (care home positivity rates, 0 to 7.6%) compared to 13 individuals (3.0 and 10.8% positivity) in two homes reporting a single case.Seropositivity across these seven homes varied between 10.7-56.5%, with four exceeding community seroprevalence in London (14.8%). Seropositivity rates for staff and residents correlated significantly (r

interpretationWe found high rates of asymptomatic infection and transmission even in care homes with no COVID-19 cases. The higher seropositivity rates compared to RT-PCR positivity highlights the true extent of the silent outbreak.

fundingPHE.

Indexed as

Asymptomatic transmissionCare homeSARS-CoV-2 outbreak

Identifiers

PMID33870248
PMCPMC7826003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.